Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
Worth a watch for a description of the breakthrough.
https://www.youtube.com/watch?v=yse17sDbDF8
Looks very well written for a change. Missed out failure to hedge though!
Seems to be an appeal in there for government support, emphasising local population's dependence on Rambler.
With revenue not even covering op costs, something major needs to happen to increase production, ie a large investment, but to any potential buyer, not the level of investment or time required to start from scratch.
Next RNS is that they haven’t paid the electricity bill
Monkey, clutching at straws there. People come and people go in all companies.
Agreed.
Moon, get the job and give us the real inside track!
Hi Pedro,
Have you been suggesting they take out further hedges? couldn't believe not seeing a RNS when copper was over 4.2
Agree and sad really that they can’t let go.
The current Copper price is luckily helping the chances of a positive outcome but I would like to see more hedging to lock in a proportion, otherwise we are relying on still more luck as before.
You are up nice and early Moon. What route did you take? With the high copper price, if we come out of this ok then I might join you!
Wasted de-ramping Monkey - share is suspended
Lets see that hedge!
Hope so. With only about 20% of this years production hedged it would be a good risk mitigator to hedge some more.
Hi Moon,
Is this in real life or in one of your dreams?
Maybe hedge a bit more
Heard about the symposium but just spotted this coverage. Surprised more has not been made of it.
https://www.medpagetoday.com/meetingcoverage/sabcsvideopearls/102475
Research presented at the San Antonio Breast Cancer Symposium highlighted the successful use of the Parsortix PC1 Clinical System for circulating tumor cell (CTC) enrichment in blood from patients with metastatic breast cancer, allowing for a variety of possible downstream analyses.
In this exclusive MedPage Today video, co-author Julie Lang, chief of breast surgery at the Cleveland Clinic in Ohio, discusses the findings of the multicenter study
Could Angle support such a programme? They must have a large testing requirement.
https://www.bbc.co.uk/news/health-64176038
A few different views here, a number predicting a very good second half 2023.
https://www.kitco.com/news/2022-12-21/Copper-prices-to-find-their-groove-in-the-second-half-of-2023.html
Taking advantage of the peaks and good risk reduction for a more predictable business.
I think there's an echo in here
Thanks worth watching
Should be doing this all of the time at various points so that the business and investors know what is coming in. Common risk management practice for many businesses who are exposed to market prices such as this or currencies for example.